Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis
Authors:
- 13 April 2018
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 27 (8) , 1259-1270
Abstract
Renal involvement is one of the most serious manifestations of systemic lupus erythematosus, but non-invasive assessment of inflammatory response in kidneys is challenging. In this study we aimed to validate markers of active lupus nephritis (LN) using urine immune profiling. Urine and serum cytokines (17-plex array) and urine mRNA expression (∼40 immune and glomerular injury genes) were measured in LN patients with active disease (n = 17) during remission (n = 16) and in healthy subjects (n = 18). Urine and serum levels of CCL2, CCL5 and CXCL10 were elevated in active LN as compared with disease remission (best discrimination for urine CXCL10 and CCL2) and correlated with LN activity. In the active disease, urinary cell transcriptome showed marked upregulation of proinflammatory cytokines (e.g. TNF, CCL2, CCL5, CXCL10), and type-1 immunity-related genes (e.g. CD3G, CD4, TBX21, IFNG). An active pattern of gene expression was also observed in four patients in remission, who had moderately increased urinary leucocyte count. Two patients from this group developed renal exacerbation during the following 3 months. Markers of type-17 immune axis (e.g. IL-17A) were not significantly increased in active LN. Active LN patients were characterized by marked increase of proinflammatory mediators in the urine. Urine cytokines (CCL2 and CXCL10) and type-1 T-cell-related gene markers in the urine sediment had similar diagnostic performance in detection of active LN.Keywords
Funding Information
- National Science Center, Poland (NN402 627940)
This publication has 40 references indexed in Scilit:
- Lupus nephritis: A critical reviewAutoimmunity Reviews, 2012
- European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studiesAnnals of the Rheumatic Diseases, 2010
- Estimation of monocyte‐chemoattractantprotein‐1 (Mcp‐1) level in patients with lupus nephritisInternational Journal of Rheumatic Diseases, 2009
- Interferon‐regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation studyArthritis & Rheumatism, 2009
- The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosusRheumatology, 2009
- CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokinesAPMIS, 2009
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patientsArthritis & Rheumatism, 2008
- Intrarenal cytokine gene expression in lupus nephritisAnnals of the Rheumatic Diseases, 2007
- Expression of T-bet, a type 1 T-helper cell transcription factor, in the urinary sediment of lupus patients predicts disease flareRheumatology, 2007